Market Overview

Recap: Invitae Q2 Earnings


Shares of Invitae (NYSE:NVTA) fell 9.39% in after-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share fell 48.08% over the past year to ($0.77), which missed the estimate of ($0.70).

Revenue of $46,191,000 declined by 13.62% from the same period last year, which beat the estimate of $39,620,000.


Invitae hasn't issued any earnings guidance for the time being.

Revenue guidance hasn't been issued by the company for now.

Conference Call Details

Date: Aug 04, 2020

Time: 04:30 PM

ET Webcast URL:


52-week high: $35.33

52-week low: $7.42

Price action over last quarter: Up 93.14%

Company Overview

Invitae Corp operates as a genetic information company in diagnostic and research industry. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions.


Related Articles (NVTA)

View Comments and Join the Discussion!

Posted-In: Earnings